- Home
- LGTY vs DNA Comparison
LGTY vs DNA Comparison
Compare LGTY & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGTY
- DNA
- Stock Information
- Founded
- LGTY 1970
- DNA 2008
- Country
- LGTY United States
- DNA United States
- Employees
- LGTY N/A
- DNA N/A
- Industry
- LGTY
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LGTY
- DNA Health Care
- Exchange
- LGTY NYSE
- DNA Nasdaq
- Market Cap
- LGTY 374.3M
- DNA 414.0M
- IPO Year
- LGTY N/A
- DNA N/A
- Fundamental
- Price
- LGTY $10.40
- DNA $9.30
- Analyst Decision
- LGTY
- DNA Hold
- Analyst Count
- LGTY 0
- DNA 7
- Target Price
- LGTY N/A
- DNA $48.17
- AVG Volume (30 Days)
- LGTY 111.9K
- DNA 843.8K
- Earning Date
- LGTY 11-14-2024
- DNA 11-06-2024
- Dividend Yield
- LGTY 4.26%
- DNA N/A
- EPS Growth
- LGTY N/A
- DNA N/A
- EPS
- LGTY 0.32
- DNA N/A
- Revenue
- LGTY $102,806,000.00
- DNA $184,335,000.00
- Revenue This Year
- LGTY N/A
- DNA N/A
- Revenue Next Year
- LGTY N/A
- DNA $12.42
- P/E Ratio
- LGTY $32.67
- DNA N/A
- Revenue Growth
- LGTY N/A
- DNA N/A
- 52 Week Low
- LGTY $8.41
- DNA $5.26
- 52 Week High
- LGTY $12.27
- DNA $75.20
- Technical
- Relative Strength Index (RSI)
- LGTY N/A
- DNA 64.83
- Support Level
- LGTY N/A
- DNA $7.14
- Resistance Level
- LGTY N/A
- DNA $8.60
- Average True Range (ATR)
- LGTY 0.00
- DNA 0.57
- MACD
- LGTY 0.00
- DNA 0.21
- Stochastic Oscillator
- LGTY 0.00
- DNA 95.14
About LGTY LOGILITY SUPPLY CHAIN SOLUTIONS INC
Logility Supply Chain Solutions Inc develops enterprise management and supply chain-related software and services. Its Services include Scenario Planning Products, Demand Planning InventoryAI+, Supply, Deployment, Supply Chain Data Management, and Supply Chain Design. The group provides services to various industries such as Food and Beverage Consumer Packaged Goods, Process Manufacturing, Industrial Manufacturing, Chemicals, and others.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.